Viral hepatitis and AIDS are significant challenges to global public health. As a leading enterprise in the field of IVD equipment and reagents, Geneway.bio is committed to eliminating these two major disease threats under the mission of "precise diagnosis, molecular screening, and benefiting all parties."

      The company's independently developed Nucleic Acid Extraction and Purification System and HBV/HCV/HIV Nucleic Acid Detection Reagents are characterized by high sensitivity and specificity, providing reliable support for accurate diagnosis. Additionally, the High-Sensitivity Molecular Reagents enable early detection and precise treatment, shortening the window period and improving prevention and control efficiency.

      Geneway.bio adheres to an innovation-driven strategy, exploring cutting-edge technologies to advance the industry. The company actively fulfills its social responsibilities, contributing to global public health efforts and safeguarding the future of human health with technology!